Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:intradigm [2023/03/05 02:01] liam [Personnel] | pharmaceutical_companies:intradigm [2024/11/09 19:40] (current) liam [External links] |
---|
| |
On November 22, 2002, Itradigm announced it had hired former [[Novavax]] CEO [[:John Spears]] as its Chairman and CEO.((//Ex-chief of Novavax hired as Intradigm CEO.// (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1)) ((//Intradigm appoints John A. Spears Chairman and CEO.// (2002, December 2). PharmaBiz. https://archive.ph/oRzIK)) | On November 22, 2002, Itradigm announced it had hired former [[Novavax]] CEO [[:John Spears]] as its Chairman and CEO.((//Ex-chief of Novavax hired as Intradigm CEO.// (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1)) ((//Intradigm appoints John A. Spears Chairman and CEO.// (2002, December 2). PharmaBiz. https://archive.ph/oRzIK)) |
| |
| On December 16, 2009, Intradigm was acquired by [[Silence Therapeutics]].((//Intradigm Corporation - Crunchbase Company Profile & Funding.// Crunchbase. Retrieved March 5, 2023, from https://www.crunchbase.com/organization/intradigm-corporation)) |
| |
===== Organization ===== | ===== Organization ===== |
==== Funding ==== | ==== Funding ==== |
| |
Investors in Intradigm include:((Bodnar, T. (2002). //Venture Capital Funds Annual Report July 2002 (p. 27).// Maryland Department of Business & Economic Development. https://web.archive.org/web/20230304190817/https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf)) | Investors in Intradigm include:((Bodnar, T. (2002). //Venture Capital Funds Annual Report July 2002 (p. 27).// Maryland Department of Business & Economic Development. https://web.archive.org/web/20230304190817/https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf)) ((//Intradigm Corporation - Funding, Financials, Valuation & Investors.// Crunchbase. Retrieved March 5, 2023, from https://crunchbase.com/organization/intradigm-corporation/company_financials)) |
| |
| * [[:Alta Partners]] |
| * [[:Astellas Venture Management]] |
| * [[Eli Lilly]] |
* [[:Emerging Technology Parters]] | * [[:Emerging Technology Parters]] |
| * [[:Frazier Healthcare Partners]] |
* [[:Maryland Venture Fund]] | * [[:Maryland Venture Fund]] |
| * [[:MediBIC Group]] |
| * [[:MP Healthcare Venture Management]] |
* [[:Novartis Venture Fund]] | * [[:Novartis Venture Fund]] |
| * [[:Roche Venture Fund]] |
==== Personnel ==== | ==== Personnel ==== |
| |
| [[:Joel Cohen]] | Member | [[:University of the Pacific]] | | | [[:Joel Cohen]] | Member | [[:University of the Pacific]] | |
| [[:Joel Jessee]] | Member | Vice President of [[Atto Bioscience]] | | | [[:Joel Jessee]] | Member | Vice President of [[Atto Bioscience]] | |
| | [[:Hamid Ghandehari]] | Member | [[:University of Maryland at Baltimore]] | |
| | [[:Archibald James Mixson]] | Member | [[:University of Maryland at Baltimore]] | |
| |
===== External links ===== | ===== External links ===== |
| |
| * [[https://wiki.whiteroseintelligence.com/en/Intradigm|Campfire Wiki]] |
* [[https://sites.google.com/housatonicits.com/home0004/research/intradigm-corp|Housatonic]] | * [[https://sites.google.com/housatonicits.com/home0004/research/intradigm-corp|Housatonic]] |